Pyrimidylaminobenzamide derivatives for the treatment of neurofibromatosis

Details for Australian Patent Application No. 2006323992 (hide)

Owner Novartis AG

Inventors Manley, Paul W.

Agent Davies Collison Cave

Pub. Number AU-B-2006323992

PCT Pub. Number WO2007/065898

Priority 60/742,781 06.12.05 US

Filing date 5 December 2006

Wipo publication date 14 June 2007

Acceptance publication date 8 July 2010

International Classifications

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

19 June 2008 PCT application entered the National Phase

  PCT publication WO2007/065898 Priority application(s): WO2007/065898

8 July 2010 Application Accepted

  Published as AU-B-2006323992

4 November 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006323993-Bifunctional air electrode

2006323986-Novel diazabicyclic aryl derivatives and their medical use